Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab and HAI Oxaliplatin in Colorectal Cancer with Liver Metastases
NCT00544349Phase 2Completed
- Sponsor
- Gustave Roussy
- Start
- Oct 2006
- Primary completion
- May 2011
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in colorectal cancer (CRC), sponsored by Gustave Roussy. Started Oct 2006; status: completed.
02
Drugs
cetuximab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00544349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00544349.